Certified by Founder Lodge
Inflammatix, Inc.
United States - Sunnyvale, California
START UP
1 Disclosed Funding Rounds $57,000,000
0 Participating Investments
-
Founded date
2016
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Inflammatix is developing an innovative point-of-care instrument platform to be used with a test to aid in the diagnosis of acute infection and sepsis by harnessing the immune system to deliv
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| September, 13 ,2024 | Series E | $57,000,000 |
Northpond Ventures
D1 Capital Partners L.P.
Iberis Capital
Raw Ventures
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Slate Medicines | $130,000,000 | (Feb 25, 2026)
Subject | $28,000,000 | (Feb 25, 2026)
Letter AI | $40,000,000 | (Feb 25, 2026)
Jampack AI | $3,200,000 | (Feb 25, 2026)
Circadian Risk Inc. | $6,000,000 | (Feb 25, 2026)
